Tizanidine

Speaker 1...and this brings us to tizanidine, an alpha-2 adrenergic agonist prescribed as a muscle relaxant for pain. While it can certainly help manage discomfort, especially from spasticity, there's growing interest in its long-term effects beyond symptom relief.

Speaker 2Right. We know that chronic, unrelieved pain itself can accelerate biological aging. For example, a study in *GeroScience* in 2025 found painful diabetic neuropathy was associated with accelerated epigenetic aging and telomere shortening compared with painless neuropathy. So, pain treatment, in theory, might mitigate this.

Speaker 1Exactly. But what about tizanidine specifically, or its drug class? The challenge is, while it addresses pain, there isn't direct, long-term evidence establishing a benefit on biological aging or all-cause mortality from tizanidine itself. The data just isn't there to make that claim.

Speaker 2And we have to consider potential long-term harms. Tizanidine can cause sedation, dizziness, and increase the risk of falls, particularly in older adults. These aren't minor issues when we're talking about overall health and longevity. It also carries risks of liver injury and interactions with other medications.

Speaker 1So, the picture is complex. Tizanidine can offer legitimate, appropriate pain relief, which is crucial. But its direct impact on processes like inflammation, the epigenetic clock, or all-cause mortality, beyond simply addressing pain, remains largely unstudied and unproven.

Speaker 2It's a critical distinction. We know pain is detrimental, but whether tizanidine, as a specific intervention, offers an anti-aging or mortality benefit, or if its side effects outweigh that in the long run, is still very much an open question for researchers.